clioquinol and plerixafor

clioquinol has been researched along with plerixafor in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garino, C; Kraus, JL; Laras, Y; Mallet, B; Moret, V; Norreel, JC; Pietrancosta, N; Quéléver, G; Rolland, A1
Clayette, P; Dereudre-Bosquet, N; Kraus, JL; Laras, Y; Marc, S; Moret, V; Pietrancosta, N; Rolland, A; Weck, C1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1

Other Studies

3 other study(ies) available for clioquinol and plerixafor

ArticleYear
1,1'-Xylyl bis-1,4,8,11-tetraaza cyclotetradecane: a new potential copper chelator agent for neuroprotection in Alzheimer's disease. Its comparative effects with clioquinol on rat brain copper distribution.
    Bioorganic & medicinal chemistry letters, 2006, Jun-15, Volume: 16, Issue:12

    Topics: Alzheimer Disease; Animals; Chelating Agents; Clioquinol; Copper; Heterocyclic Compounds, 1-Ring; Molecular Structure; Rats; Structure-Activity Relationship

2006
Synthesis and anti-HIV properties of new hydroxyquinoline-polyamine conjugates on cells infected by HIV-1 LAV and HIV-1 BaL viral strains.
    Bioorganic & medicinal chemistry letters, 2006, Dec-01, Volume: 16, Issue:23

    Topics: Anti-HIV Agents; HIV-1; Hydroxyquinolines; Molecular Structure; Polyamines; Structure-Activity Relationship

2006
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013